Skip to main content
Addgene

p39sheLL
(Plasmid #40627)

Full plasmid sequence is not available for this item.

Loading...

Ordering

This material is available to academics and nonprofits only.
Item Catalog # Description Quantity Price (USD)
Plasmid 40627 Standard format: Plasmid sent in bacteria as agar stab 1 $85

Backbone

  • Vector backbone
    p5sheLL
  • Backbone manufacturer
    J.T. Schiller, National Cancer Institute, Bethesda, MD, USA (http://home.ccr.cancer.gov/lco/default.asp)
  • Backbone size w/o insert (bp) 7862
  • Total vector size (bp) 10793
  • Modifications to backbone
    HPV5 L1 and L2 replaced with HPV39 L1 and L2
  • Vector type
    Mammalian Expression
  • Selectable markers
    Zeocin

Growth in Bacteria

  • Bacterial Resistance(s)
    Ampicillin, 100 μg/mL
  • Growth Temperature
    37°C
  • Growth Strain(s)
    DH5alpha
  • Copy number
    Low Copy

Gene/Insert 1

  • Gene/Insert name
    HPV39 L1
  • Alt name
    L1 major capsid protein
  • Alt name
    L1
  • Alt name
    HPV 39L1
  • Species
    Human Papillomavirus Type 39
  • Insert Size (bp)
    1518
  • Mutation
    Codon optimized for mammalian expression
  • GenBank ID
    Please see comments below
  • Promoter CMV

Cloning Information for Gene/Insert 1

  • Cloning method Restriction Enzyme
  • 5′ cloning site BspEI (not destroyed)
  • 3′ cloning site PspXI (not destroyed)
  • 5′ sequencing primer CMV-F
  • (Common Sequencing Primers)

Gene/Insert 2

  • Gene/Insert name
    HPV39 L2
  • Alt name
    L2 minor capsid protein
  • Alt name
    L2
  • Alt name
    HPV 39L2
  • Species
    Human Papillomavirus Type 39
  • Insert Size (bp)
    1413
  • Mutation
    Codon optimized for mammalian expression
  • GenBank ID
    Please see comments below
  • Promoter Polio IRES

Cloning Information for Gene/Insert 2

  • Cloning method Restriction Enzyme
  • 5′ cloning site NotI (not destroyed)
  • 3′ cloning site NheI (not destroyed)
  • 5′ sequencing primer Unknown
  • 3′ sequencing primer WPRE-R
  • (Common Sequencing Primers)

Terms and Licenses

  • Academic/Nonprofit Terms
  • Industry Terms
    • Not Available to Industry
Trademarks:
  • Zeocin® is an InvivoGen trademark.

Depositor Comments

Constructs representing HPV35 (p35sheLL), HPV39 (p39sheLL) and HPV59 (p59sheLL) were generated by the insertion of codon optimized genes (Blue Heron, Inc., Bothell, WA, USA) based upon consensus L1 and L2 amino acid sequences into p5shell (http://home.ccr.cancer.gov/lco/default.asp) The consensus sequences were derived from NCBI database sequences (HPV35: M74117, X74477; HPV39: M62849; HPV59: X77858, EU918767) and contemporary sequences from anonymous, HPVinfected cytology samples (HPV35 L1: JN104062–64; HPV35 L2: JN104065–67; HPV39 L1: JN104068–70; HPV39 L2: JN104071–72; HPV59 L1: JN104073–74; HPV59 L2: JN104075–77).

How to cite this plasmid ( Back to top)

These plasmids were created by your colleagues. Please acknowledge the Principal Investigator, cite the article in which the plasmids were described, and include Addgene in the Materials and Methods of your future publications.

  • For your Materials & Methods section:

    p39sheLL was a gift from Simon Beddows (Addgene plasmid # 40627 ; http://n2t.net/addgene:40627 ; RRID:Addgene_40627)
  • For your References section:

    Neutralization of non-vaccine human papillomavirus pseudoviruses from the A7 and A9 species groups by bivalent HPV vaccine sera. Draper E, Bissett SL, Howell-Jones R, Edwards D, Munslow G, Soldan K, Beddows S. Vaccine. 2011 Nov 3;29(47):8585-90. Epub 2011 Sep 21. 10.1016/j.vaccine.2011.09.021 PubMed 21939712